PHLDA1 negatively regulates Akt in the context of FGFR2, whereas loss of PHLDA1 expression contributes to cancer cell survival and FGFRi resistance due to reactivation of Akt [39, 44]. The gene discussed is FGFR2; the disease is cancer.